Application Deadline: August 4, 2020.
ISID and Pfizer Global Medical Grants announce a new competitive grant challenge to support programs working on antimicrobial stewardship campaigns throughout Africa and the Middle East.
We are seeking innovative quality improvement health services and/or educational research applications that identify and evaluate practices for successfully implementing key elements of antimicrobial stewardship programs. Programs designed for healthcare organizations, hospitals, tertiary care clinics, and educational settings are all applicable. Through this $1-million USD grant challenge, projects can request up to $100,000 USD of funds to support two-year initiatives.
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives to improve patient outcomes in areas of unmet medical need. These areas include research, quality improvement measures, and expanded educational opportunities that align with Pfizer’s medical and scientific strategies.
Pfizer’s GMG competitive grant program begins with a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an external review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps as outlined in the RFP.
For all quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.
Geographic Scope: Africa and the Middle East
• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations; public health organizations, environmental health organizations, government agencies; Research
facilities and other entities with a mission related to healthcare improvement.
• More information on organizations eligible to apply directly for a grant can be found at
• Collaborations within institutions (e.g., between departments and/or interprofessional), as well as between different institutions / organizations / associations, are strongly encouraged. Antimicrobial resistance challenges require input from multiple stakeholders where limited resources can be judiciously allocated through collaborative approaches.
Please note all partners must have a relevant role and the requesting organization must have a key role in the project. Projects with direct
organizing effort and health outcomes focusing on patient populations in Africa and the Middle East will be prioritized for funding consideration.
Proposals will be reviewed according to the following critieria:
• Innovation – Does the work address a knowledge gap not yet anwsered in the proposed country or region?.
• Data/knowledge transfer – How can other hospitals/clinics/institutions benefit from the data, methodology and/or results?
• Probability – Is there a high likelihood of generating actionable data within the project period?
• Sustainability – Does the support go primarily to researchers living within the region and the proposed project benefits the regional
• Patient Safety – Do proposals take into account potential impacts on patient safety and present ways to mitigate potential adverse effects?
How to Submit:
• Please go to www.cybergrants.com/pfizer/loi and sign in. First-time users should click “REGISTER NOW”.
• Select the following Competitive Grant Program Name: 2020 HOS RPfizer-ISID AFME Grant Challenge
• Requirements for submission:
• Complete all required sections of the online application and upload the completed LOI template (see Appendix).
• All applications must be submitted in English.
• If you encounter any technical difficulties with the website, please click the “Need Support?” link at the bottom of the page.
IMPORTANT: Be advised applications submitted through the wrong application type and/or submitted after the due date will not be reviewed by the committee.
For More Information: